FDA Orange Book · active-ingredient family
Menthol; methyl salicylate
Menthol; methyl salicylate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:SALONPAS · NDA 022029
1
Brand (NDA)
0
Generics (ANDA)
2
Listed patents
0
Exclusivity periods
Brand (NDA) products · patch
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SALONPASRLD×2 | HISAMITSU PHARM CO | NDA 022029 | — | Feb 20, 2008 |
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9233184 | Aug 01, 2027 | in 1 yr 2 mo | Product |
| 8809615 | Jan 03, 2030 | in 3 yr 7 mo | Product |
Menthol; methyl salicylate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
